Arthritis drug: Sandoz files US antitrust litigation against Amgen Ruchika Sharma14 April 2025 2:30 PM ISTSandoz is seeking an injunction to prevent Amgen from using certain patent rights to block biosimilar competition and allow Sandoz to launch Erelzi.
Lupin unveils Rymti biosimilar Etanercept in Canada Ruchika Sharma5 May 2024 10:00 AM ISTMumbai: Global pharma major Lupin Limited has announced the launch of Rymti, Lupin's first biosimilar in Canada, through its partner Sandoz...
Lupin gets Health Canada nod for plaque psoriasis treatment Rymti Ruchika Sharma13 Sept 2022 2:19 PM ISTMumbai: Global pharma major, Lupin Limited, announced today that Health Canada has approved Rymti, its biosimilar to Enbrel (etanercept), for use in...
Lupin, Mylan launch arthritis drug Nepexto in Germany Ruchika Sharma27 Aug 2020 11:53 AM ISTThe product is available as an injectable in an easy-to-use pre- filled pen and a pre-filled syringe.
Lupin, Mylan get European nod to market Nepexto for treating arthritis, psoriasis Ruchika Sharma5 Jun 2020 12:08 PM ISTMumbai: Lupin Limited and Mylan N.V. have announced that the European Commission (EC) has granted marketing authorization for Nepexto®, a biosimilar...
